
“Revenue surges, profits stall in specialty chem wildcard.”
No clear market view today
The signals we track (volume, delivery, price trend, deals, breadth and flows) aren't aligned for SANGINITAtoday. That isn't bearish, just inconclusive.
Trading near 52-week high
RSI indicates overbought conditions
India-specific risk checks.
Four fundamentals lenses on the company itself: valuation, growth, returns & margins, and financial health, judged against the stock's sector. A separate read from the Market Setup above.
Valuations look stretched
Strong revenue and profit growth
Weak returns and margins
Strong balance sheet
Data as of 3 Aug 2026, 9:47 pm